Survivor Story
Jack Moorman: Back on the golf course rebuilding his game, thanks to a cancer targeted therapy clinical study for his acute myeloid leukemia (AML).
Read Jack's Story
Jack Moorman: Back on the golf course rebuilding his game, thanks to a cancer targeted therapy clinical study for his acute myeloid leukemia (AML).
Read Jack's Story
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreIn the Experts Forecast for 2026, Fellow of the AACR Academy Dana Pe’er explains how artificial intelligence can reshape many areas of cancer research and treatment, and augment human expertise.
Read the BlogNearly 81,000 people in the United States were diagnosed with kidney cancer last year. Learn about this type of cancer, including treatment options.
Learn MoreInvesting in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Read MoreRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowAdvance registration is open for the AACR Annual Meeting 2026. Register by February 27 to receive discounted rates.
The AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn MoreThe AACR and its more than 61,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 61,000 members worldwide drive progress against cancer.
Donate Now
